BDX Stock Summary and Trading Ideas (Becton Dickinson And Company | NYSE:BDX)

Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of 2024 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.

Becton Dickinson And Company trades on the NYSE stock market under the symbol BDX.

As of December 4, 2025, BDX stock price climbed to $193.76 with 1,171,809 million shares trading.

BDX has a beta of 0.43, meaning it tends to be less sensitive to market movements. BDX has a correlation of 0.06 to the broad based SPY ETF.

BDX has a market cap of $55.30 billion. This is considered a Large Cap stock.

Last quarter Becton Dickinson And Company reported $6 billion in Revenue and $3.96 earnings per share. This fell short of revenue expectation by $-17 million and exceeded earnings estimates by $.05.

In the last 3 years, BDX traded as high as $287.32 and as low as $162.29.

The top ETF exchange traded funds that BDX belongs to (by Net Assets): VTI, VOO, IVV, SPY, VO.

BDX has underperformed the market in the last year with a price return of -10.5% while the SPY ETF gained +14.5%. BDX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +2.7% and +1.3%, respectively, while the SPY returned +6.6% and +3.3%, respectively.

BDX support price is $190.57 and resistance is $196.58 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BDX shares will trade within this expected range on the day.